General - Female Sui
Device Female Sui
General payments
$875,199
Research payments
$49,235
Through program year 2022, $875,199 in general payments and $49,235 in research payments were reported against General - Female Sui (Female Sui).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $418,552 | 34 |
| 2022 | Research | $20,000 | 1 |
| 2021 | General | $391 | 13 |
| 2020 | General | $165,033 | 379 |
| 2020 | Research | $29,235 | 3 |
| 2019 | General | $291,223 | 67 |
Breakdown
The top 5 of 28 recipients; each share is of general payments naming this product in 2022.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 16 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
493 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.